94 related articles for article (PubMed ID: 10600490)
1. Novel exons located more than 200 kb downstream of the previously described 3' exon of the K-sam gene for generating activated forms of KGF receptor.
Ueda T; Sasaki H; Aoyagi K; Narikiyo M; Tsubosa Y; Kuwahara Y; Sakamoto H; Mafune K; Yoshida T; Makuuchi M; Terada M
Biochem Biophys Res Commun; 1999 Nov; 265(3):739-45. PubMed ID: 10600490
[TBL] [Abstract][Full Text] [Related]
2. Deletion of the carboxyl-terminal exons of K-sam/FGFR2 by short homology-mediated recombination, generating preferential expression of specific messenger RNAs.
Ueda T; Sasaki H; Kuwahara Y; Nezu M; Shibuya T; Sakamoto H; Ishii H; Yanagihara K; Mafune K; Makuuchi M; Terada M
Cancer Res; 1999 Dec; 59(24):6080-6. PubMed ID: 10626794
[TBL] [Abstract][Full Text] [Related]
3. A truncated K-sam product lacking the distal carboxyl-terminal portion provides a reduced level of autophosphorylation and greater resistance against induction of differentiation.
Ishii H; Yoshida T; Oh H; Yoshida S; Terada M
Mol Cell Biol; 1995 Jul; 15(7):3664-71. PubMed ID: 7791773
[TBL] [Abstract][Full Text] [Related]
4. Expression of fibroblast growth factor gene family and its receptor gene family in the human upper gastrointestinal tract.
Iida S; Katoh O; Tokunaga A; Terada M
Biochem Biophys Res Commun; 1994 Mar; 199(3):1113-9. PubMed ID: 7511892
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF), and their receptors in human breast cells and tissues: alternative receptors.
Wilson SE; Weng J; Chwang EL; Gollahon L; Leitch AM; Shay JW
Cell Mol Biol Res; 1994; 40(4):337-50. PubMed ID: 7866434
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of K-sam protein in stomach cancer.
Hattori Y; Itoh H; Uchino S; Hosokawa K; Ochiai A; Ino Y; Ishii H; Sakamoto H; Yamaguchi N; Yanagihara K; Hirohashi S; Sugimura T; Terada M
Clin Cancer Res; 1996 Aug; 2(8):1373-81. PubMed ID: 9816310
[TBL] [Abstract][Full Text] [Related]
7. Preferential alternative splicing in cancer generates a K-sam messenger RNA with higher transforming activity.
Itoh H; Hattori Y; Sakamoto H; Ishii H; Kishi T; Sasaki H; Yoshida T; Koono M; Sugimura T; Terada M
Cancer Res; 1994 Jun; 54(12):3237-41. PubMed ID: 8205545
[TBL] [Abstract][Full Text] [Related]
8. Expression of alternatively spliced estrogen receptor alpha mRNAs is increased in breast cancer tissues.
Poola I; Speirs V
J Steroid Biochem Mol Biol; 2001 Nov; 78(5):459-69. PubMed ID: 11738556
[TBL] [Abstract][Full Text] [Related]
9. Preferential expression of the third immunoglobulin-like domain of K-sam product provides keratinocyte growth factor-dependent growth in carcinoma cell lines.
Ishii H; Hattori Y; Itoh H; Kishi T; Yoshida T; Sakamoto H; Oh H; Yoshida S; Sugimura T; Terada M
Cancer Res; 1994 Jan; 54(2):518-22. PubMed ID: 8275490
[TBL] [Abstract][Full Text] [Related]
10. Characterization of fibroblast growth factor receptor 2 overexpression in the human breast cancer cell line SUM-52PE.
Tannheimer SL; Rehemtulla A; Ethier SP
Breast Cancer Res; 2000; 2(4):311-20. PubMed ID: 11056689
[TBL] [Abstract][Full Text] [Related]
11. Exon and intron sequences, respectively, repress and activate splicing of a fibroblast growth factor receptor 2 alternative exon.
Del Gatto F; Breathnach R
Mol Cell Biol; 1995 Sep; 15(9):4825-34. PubMed ID: 7651400
[TBL] [Abstract][Full Text] [Related]
12. Control of BEK and K-SAM splice sites in alternative splicing of the fibroblast growth factor receptor 2 pre-mRNA.
Gilbert E; Del Gatto F; Champion-Arnaud P; Gesnel MC; Breathnach R
Mol Cell Biol; 1993 Sep; 13(9):5461-8. PubMed ID: 8355693
[TBL] [Abstract][Full Text] [Related]
13. K-sam gene encodes secreted as well as transmembrane receptor tyrosine kinase.
Katoh M; Hattori Y; Sasaki H; Tanaka M; Sugano K; Yazaki Y; Sugimura T; Terada M
Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2960-4. PubMed ID: 1313574
[TBL] [Abstract][Full Text] [Related]
14. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
[TBL] [Abstract][Full Text] [Related]
15. [New molecular prognostic markers in gastric carcinoma].
Yoshida K; Yasui W; Yokozaki H; Nishimoto N; Kagawa Y; Toge T; Tahara E; Yoshida T; Terada M
Gan To Kagaku Ryoho; 1998 Nov; 25(13):2021-7. PubMed ID: 9838902
[TBL] [Abstract][Full Text] [Related]
16. Biological significance of gene amplification in carcinogenesis.
Terada M; Sakamoto H; Ohmura Y; Tsuruta H; Akiyama N; Sasaki H; Katoh M; Hattori Y; Yoshida T
Princess Takamatsu Symp; 1991; 22():371-80. PubMed ID: 1844251
[TBL] [Abstract][Full Text] [Related]
17. Expression of FGFR2 BEK and K-SAM mRNA variants in normal and malignant human breast.
Luqmani YA; Bansal GS; Mortimer C; Buluwela L; Coombes RC
Eur J Cancer; 1996 Mar; 32A(3):518-24. PubMed ID: 8814701
[TBL] [Abstract][Full Text] [Related]
18. Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells.
Savagner P; Vallés AM; Jouanneau J; Yamada KM; Thiery JP
Mol Biol Cell; 1994 Aug; 5(8):851-62. PubMed ID: 7803853
[TBL] [Abstract][Full Text] [Related]
19. A novel intronic cis element, ISE/ISS-3, regulates rat fibroblast growth factor receptor 2 splicing through activation of an upstream exon and repression of a downstream exon containing a noncanonical branch point sequence.
Hovhannisyan RH; Carstens RP
Mol Cell Biol; 2005 Jan; 25(1):250-63. PubMed ID: 15601847
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a soluble KGF receptor cDNA from human corneal and breast epithelial cells.
Liu JJ; Shay JW; Wilson SE
Invest Ophthalmol Vis Sci; 1998 Dec; 39(13):2584-93. PubMed ID: 9856768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
